Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Schedule of Accrued Expenses and Other Current Liabilities [Abstract] | ||
| Accrued research and development expense | $ 1,741,083 | $ 1,754,083 |
| Accrued directors and officers (owners) compensation | 1,360,777 | 1,358,293 |
| Cash portion of the Lind Note repayments | 500,000 | 492,376 |
| Accrued compensation and employee benefits | 28,435 | 86,744 |
| Others | 569,732 | 470,133 |
| Total | $ 4,200,027 | $ 4,161,629 |